BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23991045)

  • 1. Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes.
    Hutchinson KR; Lord CK; West TA; Stewart JA
    PLoS One; 2013; 8(8):e72080. PubMed ID: 23991045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Alcohol Exposure Causes Adverse Cardiac Extracellular Matrix Changes and Dysfunction in Neonatal Mice.
    Ninh VK; El Hajj EC; Mouton AJ; Gardner JD
    Cardiovasc Toxicol; 2019 Oct; 19(5):389-400. PubMed ID: 30684169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rap1a Regulates Cardiac Fibroblast Contraction of 3D Diabetic Collagen Matrices by Increased Activation of the AGE/RAGE Cascade.
    Burr SD; Stewart JA
    Cells; 2021 May; 10(6):. PubMed ID: 34067282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
    Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2.
    Ngu JM; Teng G; Meijndert HC; Mewhort HE; Turnbull JD; Stetler-Stevenson WG; Fedak PW
    Cardiovasc Pathol; 2014; 23(6):335-43. PubMed ID: 25060386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix components isolated from diabetic mice alter cardiac fibroblast function through the AGE/RAGE signaling cascade.
    Burr SD; Stewart JA
    Life Sci; 2020 Jun; 250():117569. PubMed ID: 32201277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and Type 2 diabetic donors.
    Sedgwick B; Riches K; Bageghni SA; O'Regan DJ; Porter KE; Turner NA
    Cardiovasc Pathol; 2014; 23(4):204-10. PubMed ID: 24746387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices.
    Galie PA; Westfall MV; Stegemann JP
    Cardiovasc Pathol; 2011; 20(6):325-33. PubMed ID: 21306921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy.
    Samuel CS; Hewitson TD; Zhang Y; Kelly DJ
    Endocrinology; 2008 Jul; 149(7):3286-93. PubMed ID: 18388190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
    Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
    Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-β signaling.
    Zhang Y; Cao Y; Zheng R; Xiong Z; Zhu Z; Gao F; Man W; Duan Y; Lin J; Zhang X; Wu D; Jiang M; Zhang X; Li C; Gu X; Fan Y; Sun D
    Theranostics; 2022; 12(17):7250-7266. PubMed ID: 36438502
    [No Abstract]   [Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
    Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
    Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
    Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
    Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.